Submitted by Anonymous (not verified) on 25 April 2025 - 13:00
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Date of authorisation: 12/01/2005, Revision: 65, Status: Authorised